Stimcell Energetics (STME) Net Cash Flow Growth (1y) (2012 - 2026)
Stimcell Energetics (STME) Net Cash Flow Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -564.44% |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | -394.13% |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | -31.84% |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 76.43% |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | -34.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -34.55% |
| Nov 30, 2025 | 197.53% |
| Aug 31, 2025 | 64.47% |
| May 31, 2025 | 121.15% |
| Feb 28, 2025 | -147.27% |
| Nov 30, 2024 | 138.16% |
| Aug 31, 2024 | 43.21% |
| May 31, 2024 | -139.93% |
| Feb 29, 2024 | 630.79% |
| Nov 30, 2023 | -501.18% |
| Aug 31, 2023 | -175.38% |
| May 31, 2023 | 1,500.08% |
| Feb 28, 2023 | -58.91% |
| Nov 30, 2022 | 133.81% |
| Aug 31, 2022 | -134.34% |
| May 31, 2022 | -7.85% |
| Feb 28, 2022 | -504.06% |
| Nov 30, 2021 | 73.46% |
| Aug 31, 2021 | -43.53% |
| May 31, 2021 | 91.12% |